No new digest content identified.
National Health Commission of the People’s Republic of China [to 20 Mar 2021]
March 20: Daily briefing on novel coronavirus cases in China
On March 19, 31 provincial-level regions and the Xinjiang Production and Construction Corps on the Chinese mainland reported 4 new cases of confirmed infections.
Joint China-WHO press conference of WHO-convened Global Study of Origins of SARS-Cov-2
Transcript from February 9th, 2021
National Medical Products Administration – PRC [to 20 Mar 2021]
China approves new type of vaccine for emergency use against COVID-19
China approved a recombinant protein subunit vaccine against COVID-19 for emergency use on March 17, its developer, the Chinese Academy of Sciences’ Institute of Microbiology, said.
[See China above for detail]
Homegrown vaccines withstand coronavirus variants
No known variants of the novel coronavirus have been found to weaken the effectiveness of the four homegrown vaccines approved for use in China, a senior drug and vaccine development expert said on March 15.
China has robust system of vaccine quality supervision, says official
China has a robust vaccine quality supervision and management system that is recognized internationally, Yuan Lin, head of the Drug Supervision and Management Department of the National Medical Products Administration, said in a news briefing on March 15.
COVID-19 inoculation campaign speeding up
China is working around the clock to build COVID-19 herd immunity through its orderly and smooth rollout of vaccines, with 64.98 million doses administered as of last week, officials said on Macrh 15.